Telix brain cancer data lifts FDA approval hopes
MELBOURNE: Telix Pharmaceuticals shares are up 2.2 per cent at $16.53 after hitting an eight-month
MELBOURNE: Telix Pharmaceuticals shares are up 2.2 per cent at $16.53 after hitting an eight-month
FEATURED
Church charity now set to deliver housing diversity for seniors
Best affordable seniors housing design for Global Awards shortlisted
Compact units now set to improve seniors housing choice
Developer now seeking seniors housing proposal approval in rural setting
Seniors housing developer secures approval for new community
Church charity now set to deliver housing diversity for seniors
INNOVATION
